Komori
Governance4503Astellas Pharma Inc.Pharmaceuticals

Independent Officer Notification Form

An Independent Officers Notification Form was filed because a proposal to elect outside directors will be submitted to the annual general meeting of shareholders scheduled for 19 June 2026. All 6 outside directors have been notified as independent officers, and Takahara Shigeki (高原茂季) is newly appointed.

Worth reading
33Immaterial
Scored from 1 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
6
Independent officers (outside directors)
Wording
Definitive
How definitive the wording is.

Governance structure

Company with an Audit and Supervisory Committee
Number of independent officers6Number

This is the number of people reported to the exchange as independent officers. Whether someone is an outside officer and whether they qualify as independent are separate determinations.

Committee1
Nomination Committee and Compensation Committee
Changes this time

Takahara Shigeki (高原茂季) is listed as a newly appointed outside director. The reason for the filing is that a proposal to elect outside officers will be submitted to the annual general meeting of shareholders.

Governance structure
ItemDetails
Corporate Governance StructureCompany with an Audit and Supervisory Committee
Number of independent officers6
CommitteeNomination Committee and Compensation Committee (percentage of outside members: Not disclosed)
Changes this timeTakahara Shigeki (高原茂季) is listed as a newly appointed outside director. The reason for the filing is that a proposal to elect outside officers will be submitted to the annual general meeting of shareholders.
Items this document does not state (4)
Number of directorsPolicy on cross-shareholdingsTakeover defensesControlling shareholder

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Because proposals for the election of outside officers will be submitted to the Annual General Meeting of Shareholders.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Independent Officer Notification Form | Astellas Pharma Inc. (4503) timely disclosure | Komori